60 Degrees Pharmaceutical... (SXTP)
60 Degrees Pharmaceuticals Statistics
Share Statistics
60 Degrees Pharmaceuticals has 1.47M shares outstanding. The number of shares has increased by -39.67% in one year.
| Shares Outstanding | 1.47M |
| Shares Change (YoY) | -39.67% |
| Shares Change (QoQ) | -35.89% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.38M |
| Failed to Deliver (FTD) Shares | 138.99K |
| FTD / Avg. Volume | 7.97% |
Short Selling Information
The latest short interest is 426.62K, so 28.96% of the outstanding shares have been sold short.
| Short Interest | 426.62K |
| Short % of Shares Out | 28.96% |
| Short % of Float | 29.37% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.37 and the forward PE ratio is -3.66. 60 Degrees Pharmaceuticals's PEG ratio is 0.
| PE Ratio | -0.37 |
| Forward PE | -3.66 |
| PS Ratio | 4.83 |
| Forward PS | 1 |
| PB Ratio | 0.73 |
| P/FCF Ratio | -0.5 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for 60 Degrees Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.25 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.02 |
| Debt / FCF | -0.03 |
| Interest Coverage | -1227.87 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $202.52K |
| Profits Per Employee | $-2.65M |
| Employee Count | 3 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 0.87 |
Taxes
| Income Tax | 250 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -82.47% in the last 52 weeks. The beta is 3.42, so 60 Degrees Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 3.42 |
| 52-Week Price Change | -82.47% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 5.22 |
| Relative Strength Index (RSI) | 46.99 |
| Average Volume (20 Days) | 1.74M |
Income Statement
In the last 12 months, 60 Degrees Pharmaceuticals had revenue of 607.57K and earned -7.95M in profits. Earnings per share was -17.48.
| Revenue | 607.57K |
| Gross Profit | 222.81K |
| Operating Income | -9.71M |
| Net Income | -7.95M |
| EBITDA | -7.88M |
| EBIT | -7.95M |
| Earnings Per Share (EPS) | -17.48 |
Balance Sheet
The company has 1.66M in cash and 155.89K in debt, giving a net cash position of 1.5M.
| Cash & Cash Equivalents | 1.66M |
| Total Debt | 155.89K |
| Net Cash | 1.5M |
| Retained Earnings | -40.53M |
| Total Assets | 5.76M |
| Working Capital | 3.73M |
Cash Flow
In the last 12 months, operating cash flow was -5.65M and capital expenditures -181.11K, giving a free cash flow of -5.83M.
| Operating Cash Flow | -5.65M |
| Capital Expenditures | -181.11K |
| Free Cash Flow | -5.83M |
| FCF Per Share | -12.82 |
Margins
Gross margin is 36.67%, with operating and profit margins of -1598.97% and -1308.01%.
| Gross Margin | 36.67% |
| Operating Margin | -1598.97% |
| Pretax Margin | -1309.37% |
| Profit Margin | -1308.01% |
| EBITDA Margin | -1297.58% |
| EBIT Margin | -1598.97% |
| FCF Margin | -959.42% |
Dividends & Yields
SXTP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for SXTP.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 24, 2025. It was a backward split with a ratio of 1:5.
| Last Split Date | Feb 24, 2025 |
| Split Type | backward |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | -12.07 |
| Piotroski F-Score | 6 |